Summary
The contents of interleukin (IL)-2 and basic fibroblast growth factor (bFGF) were measured in the brain (caudate nucleus, putamen, and cerebral cortex) from control and parkinsonian patients by highly sensitive enzyme-linked immunosorbent assay (ELISA). The concentrations of IL-2 in the brain were in the order of pg/mg protein, and the values were significantly higher in the caudate and putamen from parkinsonian patients than those from control patients. However, the levels of IL-2 in the cerebral cortex showed no significant difference between parkinsonian and control patients. In contrast to IL-2, the bFGF levels in the brain were high and in the order of ng/mg protein, and there was no significant difference in the caudate and putamen between parkinsonian and control patients. Although both IL-2 and bFGF may play important roles in dopaminergic neurons as neurotrophic factors, IL-2 but not bFGF may relate to the compensatory response in the nigrostriatal dopaminergic regions in parkinsonian brain during progress of neurodegeneration.
Article PDF
Avoid common mistakes on your manuscript.
References
Bean AJ, Elde R, Cao YH, Oellig C, Tamminga C, Goldstein M, Pettersson RF, Hokfelt T (1991) Expression of acidic and basic fibroblast growth factors in the substantia nigra of rat, monkey, and human. Proc Natl Acad Sci USA 88: 10,237–10,241
Benveniste EN, Merrill JE (1986) Stimulation of oligodendroglial proloferation and maturation by interleukin-2. Nature 321: 610–613
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–254
Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin IJ (1983) A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA 80: 4,546–4,550
Chiueh CC, Burns RS, Markey SP, Jacobowitz DM, Kopin IJ (1985) Primate model of parkinsonism: selective lesion of nigrostriatal neurons by l-methyl-4-phenyl-1,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in rhesus monkeys. Life Sci 36: 213–228
Davis GC, Williams AC, Markey SP, Ebert MH, Caine ED, Reichert CM, Kopin IJ (1979) Chronic parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res 1: 249–254
Ferrara N, Ousley F, Gospodarowicz D (1988) Bovine brain astrocytes express basic fibroblast growth factor, a neurotropic and angiogenic mitogen. Brain Res 462: 223–232
Freed WJ, Morihisa JM, Spoor E, Hoffer BJ, Olson L, Seiger A, Wyatt RJ (1981) Transplanted adrenal chromaffin cells in rat brain reduce lesion-induced rotational behaviour. Nature 292: 351–352
Goetz CG, Olanow CW, Koller WC, Penn RD, Cahill D, Morantz R, Stebbins G, Tanner CM, Klawans HL, Shannon KM, Comella CL, Witt T, Cox C, Waxman M, Gauger L (1989) Multicenter study of autologous adrenal medullary transplantation to the corpus striatum in patients with advanced Parkinson's disease. N Engl J Med 320: 337–341
Greenfield SA (1992) Cell death in Parkinson's disease. In: Tipton KF (ed) Essays in biochemistry, vol 27. Portlend Press, London, pp 103–118
Grothe C, Unsicker K (1989) Immunocytochemical localization of basic fibroblast growth factor in bovine adrenal gland, ovary, and pituitary. J Histochem Cytochem 37: 1,877–1,883
Heikkila RE, Hess A, Duvoisin RC (1984) Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice. Science 224: 1,451–1,453
Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219: 979–980
Liang SM, Liang CM, Chiueh CC (1989) Visualization of interleukin-2-like molecules in MPP†lesioned rat brain. Biochem Biophys Res Commun 165: 1,312–1,318
Mogi M, Harada M, Kojima K, Kiuchi K, Nagatsu I, Nagatsu T (1987) Effects of repeated systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal tyrosine hydroxylase activity in vitro and tyrosine hydroxylase content. Neurosci Lett 80: 213–218
Mogi M, Harada M, Riederer P, Narabayashi H, Fujita K, Nagatsu T (1994a) Tumor necrosis factor-α (TNF-α) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci Lett 165: 208–210
Mogi M, Harada M, Kondo T, Riederer P, Inagaki H, Minami M, Nagatsu T (1994b) Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth fator-α are elevated in the brain from parkinsonian patients. Neurosci Lett 180: 147–150
Mogi M, Harada M, Kondo T, Riederer P, Nagatsu T (1995) Brain β2-microglobulin levels are elevated in the striatum in Parkison's disease. J Neural Transm [P-D Sect] 9: 87–92
Morgan DA, Ruscetti FW, Gallo R (1976) Selective in vitro growth of T lymphocytes from normal human bone marrows. Science 193: 1,007–1,008
Morrison RS, Kornblum HI, Leslie FM, Bradshaw RA (1987) Trophic stimulation of cultured neurons from neonatal rat brain by epidermal growth factor. Science 238: 72–75
Otto D, Unsicker K (1990) Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice. J Neurosci 10: 1912–1921
Sternberg EM (1989) Monokines, lymphokines and the brain. In: Cruse JM, Lewis Jr RE (eds) The year in immunology 1988: immunoregulatory cytokines and cell growth, vol 5. Karger, Basel, pp 205–217
Snyder SH (1991) Parkinson's disease, fresh factors to consider. Nature 350: 195
Yoshida K, Gage FH (1991) Fibroblast growth factors stimulate nerve growth factor synthesis and secretion by astrocytes. Brain Res 538: 118–126
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mogi, M., Harada, M., Kondo, T. et al. Interleukin-2 but not basic fibroblast growth factor is elevated in parkinsonian brain. J. Neural Transmission 103, 1077–1081 (1996). https://doi.org/10.1007/BF01291792
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01291792